Company intelligence / Profile preview

Kanan Therapeutics

Westlake Village, California, United States

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Kanan Therapeutics is a private, development-stage biopharmaceutical company based in Westlake Village, California. Publicly available information on the company is sparse, but multiple sources describe it as a cardiovascular drug development company focused on innovative therapies for areas of unmet medical need. The company appears to have been founded in 2015, and available executive biographies identify Frank Watanabe as a co-founder and former chief operating officer. No clinical-stage assets, named drug candidates, or detailed pipeline disclosures were identified in readily available public sources.

Therapeutic areas: Cardiovascular
Industry: Biotech

Beyond the preview

Go deeper on Kanan Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kanan Therapeutics.

Explore the full profile